A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population

Gene

Volumn 529, Issue 1, 2013, Pages 125-130

  Zhang, Ning ^a   Huo, Qiang ^a   Wang, Xiaolong ^a   Chen, Xi ^a   Long, Li ^a   Jiang, Liyu ^a   Ma, Tingting ^a   Yang, Qifeng ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Key Laboratory of Digital Human and Clinical Anatomy   (China)

Author keywords

Breast cancer; MiR 27a; Prognosis; Rs895819; SNP; Susceptibility

Indexed keywords

ALANINE; ESTROGEN; GUANINE; MICRORNA; MIR 27A; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST CANCER; ER; ESTROGEN RECEPTOR; HARDY-WEINBERG EQUILIBRIUM; HER2; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2; HWE; IHC; IMMUNOHISTOCHEMISTRY; MIR-27A; PCR; POLYMERASE CHAIN REACTION; PR; PROGESTOGEN RECEPTOR; PROGNOSIS; RS895819; SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS); SNP; SUSCEPTIBILITY;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84883556129     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.041     Document Type: Article

References (38)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Calin G.A., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005, 353:1793-1801.
3. Catucci I., et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res. Treat. 2012, 133:805-807.
4. Duan R., Pak C., Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet. 2007, 16:1124-1131.
5. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
6. Friedman L.C., et al. Medical and psychosocial predictors of delay in seeking medical consultation for breast symptoms in women in a public sector setting. J. Behav. Med. 2006, 29:327-334.
7. Gao L.B., et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2011, 125:571-574.
8. Gorin S.S., Heck J.E., Cheng B., Smith S.J. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch. Intern. Med. 2006, 166:2244-2252.
9. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
10. Hezova R., et al. Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J. Gastroenterol. 2012, 18:2827-2831.
11. Kontorovich T., Levy A., Korostishevsky M., Nir U., Friedman E. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int. J. Cancer 2010, 127:589-597.
12. Kothari A., Fentiman I.S. 22. Diagnostic delays in breast cancer and impact on survival. Int. J. Clin. Pract. 2003, 57:200-203.
13. Li X., et al. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis. PLoS One 2012, 7:e44916.
14. Liu X., et al. Identification of novel variants of metadherin in breast cancer. PLoS One 2011, 6:e17582.
15. McLaughlin J.M., Anderson R.T., Ferketich A.K., Seiber E.E., Balkrishnan R., Paskett E.D. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J. Clin. Oncol. 2012, 30:4493-4500.
16. Peng S., Kuang Z., Sheng C., Zhang Y., Xu H., Cheng Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig. Dis. Sci. 2010, 55:2288-2293.
17. Rodriguez S., Gaunt T.R., Day I.N. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 2009, 169:505-514.
18. Ruiterkamp J., Ernst M.F. The role of surgery in metastatic breast cancer. Eur. J. Cancer 2011, 47(Suppl. 3):S6-S22.
19. Safe S., Abdelrahim M. Sp transcription factor family and its role in cancer. Eur. J. Cancer 2005, 41:2438-2448.
20. Shen J., Ambrosone C.B., DiCioccio R.A., Odunsi K., Lele S.B., Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008, 29:1963-1966.
21. Shi D., et al. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One 2012, 7:e46566.
22. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
23. Sun Q., et al. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci. 2010, 101:2241-2247.
24. Volinia S., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261.
25. Von Kleist S. Prognostic factors in breast cancer: theoretical and clinical aspects (review). Anticancer Res. 1996, 16:3907-3912.
26. Wolff A.C., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007, 25:118-145.
27. Xu B., et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2010, 70:467-472.
28. Yang R., Burwinkel B. A bias in genotyping the miR-27a rs895819 and rs11671784 variants. Breast Cancer Res. Treat. 2012, 134:899-901.
29. Yang Q., Moran M.S., Haffty B.G. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Res. Treat. 2009, 115:343-348.
30. Yang R., et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res. Treat. 2010, 121:693-702.
31. Yang Q., et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 2012, 10.1038/onc.2012.569.
32. Yoon K.A., et al. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2012, 144:794-807.
33. Zeng Y., Cullen B.R. Sequence requirements for micro RNA processing and function in human cells. RNA 2003, 9:112-123.
34. Zeng Y., Yi R., Cullen B.R. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 2005, 24:138-148.
35. Zhang N., Kong X., Yan S., Yuan C., Yang Q. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci. 2010, 101:2375-2383.
36. Zhang M., et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur. J. Cancer Care (Engl.) 2012, 21:274-280.
37. Zhong S., Chen Z., Xu J., Li W., Zhao J. Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol. Biol. Rep. 2013, 40(4):3181-3186. 10.1007/s11033-012-2392-3.
38. Zhou Y., et al. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J. Cancer Res. Clin. Oncol. 2012, 138(6):939-945. 10.1007/s00432-012-1164-8.